In Transition
Coming soon, Novartis
The Novartis board member transition is in progress. The new appointment will be announced soon.
- About
- Our Solutions
- Our Solutions
- Our Solutions Interactive Tool
- All Solutions
- Advancing Safety Analytics
- Clinical Content & Reuse
- Clinical Data Standards
- Clinical Data Transparency
- Clinical Research Access & Information Exchange
- Clinical Research Awareness
- Common Serious Adverse Events (SAE) Fields
- Comparator Network
- Data Monitoring Committee
- DataCelerate®
- Digital Data Flow
- Diversity of Participants in Clinical Trials
- eConsent
- eLabels
- Embedded Pragmatic Clinical Trials
- Enabling Translational Safety
- eSource
- Historical Trial Data Sharing
- Intelligent Automation Opportunities in Pharmacovigilance
- Interpretation of Clinical Guidances & Regulations
- Interpretation of Pharmacovigilance Guidances & Regulations
- Investigator Registry
- Modernization of Statistical Analytics
- Modernizing Clinical Trial Conduct
- Modernizing ICSR Management
- Optimizing Data Collection
- Participant Data Return
- Patient Experience
- Patient Technology
- Pharmacovigilance Agreements Optimization
- Privacy Methodology for Data Sharing
- Protocol Deviations
- Quality Management System
- Rapid Signal Assessment Using Real World Data
- Real World Data
- Risk Based Monitoring
- Shared Investigator Platform
- Site Qualification and Training
- Value of Safety Information Data Sources
- Events
- News Center
- Blog
- Engage With Us
- Join Our Awareness & Implementation Community
- Resources for Disruptions to Trials
- BioCelerate
- Member Login
X